Yew Bio-Pharm Group, Inc. Proceeds from Stock Options Exercised
Yew Bio-Pharm Group, Inc. reported Proceeds from Stock Options Exercised of $40.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-05-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2020-05-14
- Yew Bio-Pharm Group, Inc. proceeds from stock options exercised for the quarter ending 2018-12-31 was $0.00.
- Yew Bio-Pharm Group, Inc. proceeds from stock options exercised for fiscal 2018 was $40.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-14 | $40.00K 10-K · filed 2020-05-14 | |
| 2018-09-30 | $40.00K 10-Q · filed 2019-11-14 |